Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

ArgBP2b Inhibitors

ArgBP2b inhibitors are a class of chemical compounds designed to target the ArgBP2b protein, which plays a crucial role in intracellular signaling pathways. ArgBP2b is part of the ArgBP2 family, known for their involvement in various cellular processes, including actin cytoskeleton organization, cell adhesion, and migration. The inhibition of ArgBP2b can significantly affect these biological pathways, disrupting normal cellular functions such as cytoskeletal dynamics, protein-protein interactions, and signal transduction. ArgBP2b itself contains several domains, including SH3 and WW domains, which are important for its interaction with other proteins, and inhibitors are often designed to disrupt these specific interactions. By binding to these domains or allosteric sites, ArgBP2b inhibitors can modulate the protein's activity and its interactions with key cellular components.

ArgBP2b inhibitors are typically studied for their ability to affect cellular architecture and mechanical properties. This includes influencing the remodeling of the actin cytoskeleton, which is essential for maintaining cell shape and facilitating movement. These inhibitors are also used in research focused on cellular adhesion mechanisms, where ArgBP2b plays a pivotal role by interacting with adhesion molecules at the membrane. Changes in these processes can have widespread effects on cellular behavior, particularly in dynamic environments where cells undergo migration or structural changes. Researchers investigating the molecular mechanics of cellular structure often employ ArgBP2b inhibitors to gain a deeper understanding of protein networks involved in these processes, providing insights into how intracellular signaling cascades are regulated at the molecular level.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

This compound may downregulate ArgBP2b by increasing acetylation of histones, enhancing the accessibility of chromatin to repressive transcription factors specific to the ArgBP2b gene.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By reducing methylation levels at the ArgBP2b gene promoter, 5-Azacytidine could lead to a decrease in ArgBP2b mRNA transcription.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D may inhibit the synthesis of ArgBP2b mRNA by intercalating into DNA and preventing RNA polymerase from effectively transcribing the gene.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

This antibiotic could reduce the levels of ArgBP2b protein by hindering the elongation phase of mRNA translation, leading to a decrease in protein synthesis.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

By inhibiting mTOR signaling, Rapamycin might indirectly decrease the translation efficiency of ArgBP2b mRNA into functional proteins.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

α-Amanitin may strongly inhibit RNA polymerase II, leading to a sharp decline in the transcription of the ArgBP2b gene.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

This compound could reduce ArgBP2b production by hindering the phosphorylation of RNA polymerase II, a critical step required for the initiation and elongation phases of transcription.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG-132 may decrease the degradation of ubiquitinated transcription factors that negatively regulate ArgBP2b expression, leading to lower protein levels.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

If Sp1 is a positive regulator of ArgBP2b, Mithramycin A could downregulate expression by inhibiting Sp1's DNA binding and transcriptional activity.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid might decrease ArgBP2b expression by promoting the degradation of transcripts or by repressing transcription through retinoic acid receptor-mediated signaling.